Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, discusses the trend of patients consulting Dr.Google - finding information of varied quality on the internet.

GRACEcast Cancer 101 Video

Dr. Larry Einhorn: What is Your Opinion of Patients and Caregivers Searching the Internet for Information?

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, gives his view on whether a supercomputer such as Watson will be able to use complex algorithms to improve cancer care.

Dr. Larry Einhorn: Are You Optimistic That a Supercomputer Such as Watson Will Be Able To Improve Cancer Care?

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, gives his view on more widespread availability of new mutation tests.

Dr. Larry Einhorn: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, on what he sees as the most significant changes in cancer care in the last decade or two.

Dr. Larry Einhorn on "What Have Been the Most Significant Changes in Cancer Care over the Past Decade or Two?"

Dr. Larry Einhorn, Distinguished Professor of Medicine at Indiana Univ and former ASCO president, discusses leading challenges he sees for effective delivery of the best cancer care over the next decade.

Dr. Larry Einhorn: What are the Biggest Challenges We Face in Delivering Effective Cancer Care in the Next Decade?

Dr. Larry Einhorn, Indiana University, expresses his concerns about the cost of developing cancer drugs and the challenge of paying for extremely expensive cancer treatments that are given in anticipation of modest clinical benefits.

Dr. Larry Einhorn: Will Costs of Care Limit Our Ability to Deliver Cancer Treatments?

Dr. Larry Einhorn, Indiana University, explains why some cancers such as testicular cancer can have such a high cure rate while most others are far more challenging to cure with our current systemic therapies, offering an optimistic view of the future.

Dr. Larry Einhorn: How Can We Replicate the High Cure Rates We've Achieved for Testicular Cancer in a Wide Range of Cancers?

Dr. Ramalingam answers questions on the changing landscape of cancer clinical trials and how new studies are being designed in the new era of molecular oncology.

Dr. Suresh Ramalingam: Question and Answer Session on Clinical Trials in Oncology (video)

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, dispels several myths that have created barriers to patient participation in clinical trials and highlights the rights of a patient interested in enrolling on a study.

Dr. Suresh Ramalingam: Myths, Facts, and Patient Rights in Clinical Trials (video)

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, explains the process of developing a clinical trial, from identifying the most important questions to navigating it through the design and implementation process and enrolling patients.

Dr. Suresh Ramalingam: How Are Clinical Trials Developed and Initiated? (video)

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, reviews what constitutes a clinical trial and discusses the phases of studies in the process of clinical research.

Dr. Suresh Ramalingam: What is a Clinical Trial? (video)

Dr. Jack West thanks the GRACE community for their generous support in our recent Annual Appeal and offers his wishes for a happy and healthy 2013.

Thanks so much for your support in 2012: Here's to a great 2013!

Dr. Jack West wishes the cancer community a happy holiday season from GRACE.

Happy Holidays from Dr West and GRACE

Dr. Jack West describes a potentially efficient way to improve delivery of increasingly specialized care to broad geographic areas by collaboration of healthcare network teams using telemedicine solutions currently available.

Using Telemedicine to Deliver Optimal Subspecialty Care Across Healthcare Networks

Dr. Jack West discusses the pros and cons of repeat biopsies of tumors in the setting of "acquired resistance" to targeted therapies, with a specific consideration of whether this should be considered a standard of care.

Do we need to do repeat biopsies with disease progression?

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

hubhopper

GRACEcast Cancer 101 Video

hubhopper